Phase II study of adjuvant gemcitabine plus docetaxel (GD) for completely resected stage I-IV high grade uterine leiomyosarcoma (HGuLMS)
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. L. Hensley, J. Larkin, N. Ishill, N. Abu-Rustum, P. Sabbatini, J. Konner, W. Tew, D. Spriggs, C. A. Aghajanian
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3009934648
